Yasuo Saijo

12.1k total citations · 1 hit paper
118 papers, 5.2k citations indexed

About

Yasuo Saijo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yasuo Saijo has authored 118 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 49 papers in Pulmonary and Respiratory Medicine and 39 papers in Molecular Biology. Recurrent topics in Yasuo Saijo's work include Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (30 papers) and Immunotherapy and Immune Responses (15 papers). Yasuo Saijo is often cited by papers focused on Lung Cancer Treatments and Mutations (37 papers), Lung Cancer Research Studies (30 papers) and Immunotherapy and Immune Responses (15 papers). Yasuo Saijo collaborates with scholars based in Japan, Canada and United States. Yasuo Saijo's co-authors include Toshihiro Nukiwa, Makoto Maemondo, Akira Inoue, Toshiaki Kikuchi, Masahiko Kanehira, Hong Xin, Yuichiro Kimura, Koichi Hagiwara, Kazuhiro Usui and Ruowen Sun and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yasuo Saijo

113 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

2012 427 citations Akira Inoue, Kunihiko Kobayashi et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Yasuo Saijo

Since Specialization

Citations

This map shows the geographic impact of Yasuo Saijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Saijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Saijo more than expected).

Fields of papers citing papers by Yasuo Saijo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Saijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Saijo. The network helps show where Yasuo Saijo may publish in the future.

Co-authorship network of co-authors of Yasuo Saijo

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Saijo. A scholar is included among the top collaborators of Yasuo Saijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Saijo. Yasuo Saijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens 2023 ·Japanese Journal of Clinical Oncology ·(unknown), Tatsuo Kanda, Yoshifumi Matsumoto, Takashi Ishikawa, Seiichi Hirota, Yasuo Saijo	1
2	Efficacy of BRAF inhibitor and anti-EGFR antibody in colorectal neuroendocrine carcinoma 2022 ·Clinical Journal of Gastroenterology ·(unknown), Yoshifumi Shimada, Yoshifumi Matsumoto, (unknown), Qiliang Zhou, Kenta Sasaki, Masato Moriyama, Kosuke Yoshihara, Manabu Natsumeda, (unknown), Yasumasa Takii, Gen Watanabe, Hajime Umezu, Shujiro Okuda, Takeshi Ikeuchi, Toshifumi Wakai, Yasuo Saijo	6
3	382MO The preliminary safety result of a phase II study of osimertinib in combination with platinum + pemetrexed in patients with previously untreated EGFR-mutated advanced NSCLC (NEJ032C/LOGIK1801: OPAL) 2020 ·Annals of Oncology ·Ryo Morita, Hajime Asahina, Kentaro Tanaka, Ryota Saito, Shunichi Sugawara, Ryo Ko, Koichi Azuma, Satoshi Morita, Yasuo Saijo, Makoto Maemondo, Masahiro Seike, (unknown), Kenji Sugio, Kunihiko Kobayashi	1
4	A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil 2019 ·International Cancer Conference Journal ·(unknown), (unknown), Naoto Suzuki, Izumi Shimada, (unknown), Yasuo Saijo, Akira Toyama	14
5	Trachea Engineering Using a Centrifugation Method and Mouse-Induced Pluripotent Stem Cells 2018 ·Tissue Engineering Part C Methods ·Qiliang Zhou, (unknown), (unknown), (unknown), Yoshifumi Matsumoto, Masato Moriyama, Yoichi Ajioka, Yasuo Saijo	5
6	A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer 2017 ·PLoS ONE ·Yoshiaki Inoue, (unknown), Hitoshi Miyazawa, Hiromitsu Ohta, (unknown), Yoshiaki Nagai, Kunihiko Kobayashi, Yasuo Saijo, Masanori Tsuchida, Mitsuo Nakayama, Koichi Hagiwara	10
7	Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation 2015 ·Lung Cancer ·Tatsuro Fukuhara, Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita, Yuka Fujita, Yasuo Saijo, Koichi Hagiwara, Satoshi Morita, Toshihiro Nukiwa	26
8	Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization 2011 ·Molecular Medicine ·Kazuhiro Suzuki, Ruowen Sun, (unknown), Masahiko Kanehira, Takenori Takahata, Jugoh Itoh, Akihiro Umezawa, Hiroshi Kijima, Shinsaku Fukuda, Yasuo Saijo	190
9	Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations 2011 ·Journal of Thoracic Oncology ·Hironori Satoh, Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Yasuo Saijo, Hirohisa Yoshizawa, Koichi Hagiwara, Toshihiro Nukiwa	46
10	First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy 2009 ·Journal of Clinical Oncology ·Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, Makoto Maemondo, Shoji Okinaga, Iwao Mikami, Masahiro Ando, Koichi Yamazaki, Yasuo Saijo, Akihiko Gemma, Hitoshi Miyazawa, Tomoaki Tanaka, Kenji Ikebuchi, Toshihiro Nukiwa, Satoshi Morita, Koichi Hagiwara	369
11	Randomized phase II trial of weekly paclitaxel combined with carboplatin versus standard paclitaxel combined with carboplatin for elderly patients with advanced non-small-cell lung cancer 2009 ·Annals of Oncology ·Tomohiro Sakakibara, Akira Inoue, Shunichi Sugawara, Makoto Maemondo, Takashi Ishida, Kazuhiro Usui, Tetsuya Abe, (unknown), Hiroshi Watanabe, Yasuo Saijo, T. Nukiwa	24
12	Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402 2008 ·Journal of Clinical Oncology ·Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, Makoto Maemondo, Toshiro Suzuki, Kazunori Gomi, Shingo Takanashi, Chieko Inoue, Minoru Inage, Hiroshi Yokouchi, Hiroshi Watanabe, (unknown), Yasuo Saijo, Osamu Ishimoto, Fumihiro Hommura, Toshihiro Nukiwa	188
13	Adenocarcinoma With Epidermal Growth Factor Receptor Gene Mutations in Three Siblings 2008 ·Journal of Thoracic Oncology ·Tomohiro Sakakibara, Yasuo Saijo, Tatsuro Fukuhara, Kazunori Gomi, Akira Inoue, Osamu Ishimoto, Shunichi Sugawara, Toshihiro Nukiwa	1
14	Infiltration of COX-2–expressing macrophages is a prerequisite for IL-1β–induced neovascularization and tumor growth 2005 ·Journal of Clinical Investigation ·Shintaro Nakao, Takashi Kuwano, Chikako Tsutsumi‐Miyahara, (unknown), Yusuke Kimura, Shinjiro Hamano, Koh‐Hei Sonoda, Yasuo Saijo, Toshihiro Nukiwa, Robert M. Strieter, Tatsuro Ishibashi, Michihiko Kuwano, Mayumi Ono	246
15	Multifunctional interleukin‐1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion‐, invasion‐ and angiogenesis‐related molecules 2003 ·Cancer Science ·Seiji Yano, Hiroshi Nokihara, Akihiko Yamamoto, Hisatsugu Goto, Hirohisa Ogawa, Takanori Kanematsu, Toyokazu Miki, Hisanori Uehara, Yasuo Saijo, Toshihiro Nukiwa, Saburo Sone	68
16	Proinflammatory Cytokine IL-1β Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction 2002 ·The Journal of Immunology ·Yasuo Saijo, Masashi Tanaka, Makoto Miki, Kazuhiro Usui, Takuji Suzuki, Makoto Maemondo, Hong Xin, Ryushi Tazawa, Toshiaki Kikuchi, Kouji Matsushima, Toshihiro Nukiwa	205
17	High Level of Vascular Endothelial Growth Factor in Hemorrhagic Pleural Effusion of Cancer 2002 ·Oncology ·Osamu Ishimoto, Yasuo Saijo, (unknown), Yuichiro Kimura, Masahito Ebina, (unknown), (unknown), Yushi Nakai, Toshihiro Nukiwa	40
18	Non‐mutated tumor‐rejection antigen peptides elicit type‐I allergy in the majority of healthy individuals 2002 ·Tissue Antigens ·Shinya Ohkouchi, Akira Yamada, (unknown), Takashi Mine, Kenji Harada, Shigeki Shichijo, Yoshiaki Maeda, Yasuo Saijo, T. Nukiwa, K Itoh	27
19	Contiguous Four‐guanosine Sequence in c‐myc Antisense Phosphorothioate Oligonucleotides Inhibits Cell Growth on Human Lung Cancer Cells: Possible Involvement of Cell Adhesion Inhibition 1997 ·Japanese Journal of Cancer Research ·Yasuo Saijo, (unknown), Tatsuya Abé, Ken Satoh, Toshihiro Nukiwa	23
20	The effect of antisense p120 construct on p120 expression and cell proliferation in human breast cancer MCF-7 cells 1993 ·Cancer Letters ·Yasuo Saijo, László Perlaky, Benigno C. Valdez, Rose K. Busch, Dale Henning, Wei Wei Zhang, Harris Busch	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact